0001209191-13-022914.txt : 20130429 0001209191-13-022914.hdr.sgml : 20130427 20130429165058 ACCESSION NUMBER: 0001209191-13-022914 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130423 FILED AS OF DATE: 20130429 DATE AS OF CHANGE: 20130429 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Pacira Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001396814 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5 SYLVAN WAY STREET 2: SUITE 100 CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: 973-254-3560 MAIL ADDRESS: STREET 1: 5 SYLVAN WAY STREET 2: SUITE 100 CITY: PARSIPPANY STATE: NJ ZIP: 07054 FORMER COMPANY: FORMER CONFORMED NAME: PACIRA INC DATE OF NAME CHANGE: 20080318 FORMER COMPANY: FORMER CONFORMED NAME: Blue Acquisition Corp DATE OF NAME CHANGE: 20070418 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: EVNIN LUKE CENTRAL INDEX KEY: 0001134657 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35060 FILM NUMBER: 13792335 MAIL ADDRESS: STREET 1: THE JOHN HANCOCK TOWER STREET 2: 200 CLARENDON STREET, 54TH STREET CITY: BOSTON STATE: MA ZIP: 02116 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2013-04-23 0 0001396814 Pacira Pharmaceuticals, Inc. PCRX 0001134657 EVNIN LUKE C/O MPM ASSET MANAGEMENT 200 CLARENDON STREET, 54TH FLOOR BOSTON MA 02116 1 0 0 0 Common Stock 2013-04-23 4 S 0 108115 30.00 D 1169789 I See Footnote Common Stock 2013-04-24 4 S 0 6303 30.04 D 1163486 I See Footnote Common Stock 22746 D This transaction was pursuant to a 10b5-1 Plan. The shares were sold as follows: 101,325 by MPM BioVentures IV-QP, L.P. ("BV IV QP"), 3,903 by MPM BioVentures IV GmbH & Co. Beteiligungs KG ("BV IV KG") and 2,887 by MPM Asset Management Investors BV4 LLC ("AM BV4"). MPM BioVentures IV GP LLC and MPM BioVentures IV LLC ("BV LLC") are the direct and indirect general partners of BV IV QP and BV IV KG and BV LLC is the manager of AM BV4. The Reporting Person is a member of BV LLC. The shares are held as follows: 1,096,401 by BV IV QP, 42,243 by BV IV KG and 31,145 by AM BV4. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein. The shares were sold as follows: 5,907 by BV IV QP, 228 by BV IV KG and 168 by AM BV4. The shares are held as follows: 1,090,494 by BV IV QP, 42,015 by BV IV KG and 30,977 by AM BV4. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein. /s/ Luke Evnin 2013-04-29